{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:40:17Z","timestamp":1789609217204,"version":"build-2803163510"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1097\/spc.0000000000000211","type":"journal-article","created":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T12:10:44Z","timestamp":1461240644000},"page":"137-142","source":"Crossref","is-referenced-by-count":12,"title":["Autoantibodies and pain"],"prefix":"10.1097","volume":"10","author":[{"given":"John M.","family":"Dawes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20211004","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1474-4422(11)70096-5","article-title":"Autoantibodies associated with diseases of the CNS: new developments and future challenges","volume":"10","author":"Vincent","year":"2011","journal-title":"Lancet Neurol"},{"key":"R2-5-20211004","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.24200","article-title":"Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms","volume":"76","author":"Irani","year":"2014","journal-title":"Ann Neurol"},{"key":"R3-5-20211004","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1212\/WNL.0b013e3182698cab","article-title":"Chronic pain as a manifestation of potassium channel-complex autoimmunity","volume":"79","author":"Klein","year":"2012","journal-title":"Neurology"},{"key":"R4-5-20211004","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nn.3881","article-title":"Unbiased classification of sensory neuron types by large-scale single-cell RNA sequencing","volume":"18","author":"Usoskin","year":"2015","journal-title":"Nat Neurosci"},{"key":"R5-5-20211004","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrn3946","article-title":"Crosstalk between the nociceptive and immune systems in host defence and disease","volume":"16","author":"McMahon","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"R6-5-20211004","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1474-4422(12)70134-5","article-title":"The role of the immune system in the generation of neuropathic pain","volume":"11","author":"Calvo","year":"2012","journal-title":"Lancet Neurol"},{"key":"R7-5-20211004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2013.10.004","article-title":"Chemokines as peripheral pain mediators","volume":"557","author":"Dawes","year":"2013","journal-title":"Neurosci Lett"},{"key":"R8-5-20211004","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-3-662-46450-2_8","article-title":"The role of glia in the spinal cord in neuropathic and inflammatory pain","volume":"227","author":"Old","year":"2015","journal-title":"Handb Exp Pharmacol"},{"key":"R9-5-20211004","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"R10-5-20211004","doi-asserted-by":"crossref","first-page":"18161","DOI":"10.1523\/JNEUROSCI.3506-13.2013","article-title":"Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors","volume":"33","author":"Ohkawa","year":"2013","journal-title":"J Neurosci"},{"key":"R11-5-20211004","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.23577","article-title":"Morvan syndrome: clinical and serological observations in 29 cases","volume":"72","author":"Irani","year":"2012","journal-title":"Ann Neurol"},{"key":"R12-5-20211004","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1111\/ene.12164","article-title":"Dramatic improvement after rituximab in a patient with paraneoplastic treatment-refractory Morvan syndrome associated with anti-CASPR2 antibodies","volume":"20","author":"Ong","year":"2013","journal-title":"Eur J Neurol"},{"key":"R13-5-20211004","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tins.2013.12.002","article-title":"Opening paths to novel analgesics: the role of potassium channels in chronic pain","volume":"37","author":"Tsantoulas","year":"2014","journal-title":"Trends Neurosci"},{"key":"R14-5-20211004","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1083\/jcb.200305018","article-title":"Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1","volume":"162","author":"Poliak","year":"2003","journal-title":"J Cell Biol"},{"key":"R15-5-20211004","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.neuron.2012.12.035","article-title":"Kv1.1 channels act as mechanical brake in the senses of touch and pain","volume":"77","author":"Hao","year":"2013","journal-title":"Neuron"},{"key":"R16-5-20211004","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/nn.3438","article-title":"A long noncoding RNA contributes to neuropathic pain by silencing Kcna2 in primary afferent neurons","volume":"16","author":"Zhao","year":"2013","journal-title":"Nat Neurosci"},{"key":"R17-5-20211004","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1152\/jn.1992.68.3.734","article-title":"Onset of a painful peripheral neuropathy in rat: a partial and differential deafferentation and spontaneous discharge in A beta and A delta primary afferent neurons","volume":"68","author":"Kajander","year":"1992","journal-title":"J Neurophysiol"},{"key":"R18-5-20211004","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/nm.3978","article-title":"Inhibition of mechanical allodynia in neuropathic pain by TLR5-mediated A-fiber blockade","volume":"21","author":"Xu","year":"2015","journal-title":"Nat Med"},{"key":"R19-5-20211004","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J Clin Invest"},{"key":"R20-5-20211004","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/ard.2008.105759","article-title":"Arthritis development in patients with arthralgia is strongly associated with anticitrullinated protein antibody status: a prospective cohort study","volume":"69","author":"Bos","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R21-5-20211004","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jcla.21638","article-title":"Anticyclic citrullinated peptide antibody and rheumatoid factor in south Tunisian patients with rheumatoid arthritis: association with disease activity and severity","volume":"28","author":"Hamad M. Ben","year":"2014","journal-title":"J Clin Lab Anal"},{"key":"R22-5-20211004","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/annrheumdis-2015-208094","article-title":"Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism","volume":"75","author":"Wigerblad","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R23-5-20211004","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1526-4637.2002.02018.x","article-title":"Human pooled immunoglobulin in the treatment of chronic pain syndromes","volume":"3","author":"Goebel","year":"2002","journal-title":"Pain Med"},{"key":"R24-5-20211004","doi-asserted-by":"crossref","first-page":"152","DOI":"10.7326\/0003-4819-152-3-201002020-00006","article-title":"Intravenous immunoglobulin treatment of the complex regional pain syndrome: a randomized trial","volume":"152","author":"Goebel","year":"2010","journal-title":"Ann Intern Med"},{"key":"R26-5-20211004","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ejp.572","article-title":"Improvement of complex regional pain syndrome after plasmapheresis","volume":"19","author":"Blaes","year":"2015","journal-title":"Eur J Pain"},{"key":"R27-5-20211004","first-page":"383","article-title":"Plasma exchange therapy in patients with complex regional pain syndrome","volume":"18","author":"Aradillas","year":"2015","journal-title":"Pain Physician"},{"key":"R28-5-20211004","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.pain.2013.10.011","article-title":"A CRPS-IgG-transfer-trauma model reproducing inflammatory and positive sensory signs associated with complex regional pain syndrome","volume":"155","author":"T\u00e9kus","year":"2014","journal-title":"Pain"},{"key":"R29-5-20211004","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ejpain.2010.10.005","article-title":"The passive transfer of immunoglobulin G serum antibodies from patients with longstanding Complex Regional Pain Syndrome","volume":"15","author":"Goebel","year":"2011","journal-title":"Eur J Pain"},{"key":"R30-5-20211004","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.pain.2011.06.012","article-title":"Autoimmunity against the \u03b22 adrenergic receptor and muscarinic-2 receptor in complex regional pain syndrome","volume":"152","author":"Kohr","year":"2011","journal-title":"Pain"},{"key":"R31-5-20211004","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.pain.2014.09.022","article-title":"Longstanding complex regional pain syndrome is associated with activating autoantibodies against alpha-1a adrenoceptors","volume":"155","author":"Dubuis","year":"2014","journal-title":"Pain"},{"key":"R32-5-20211004","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10194-008-0064-4","article-title":"Antineuronal antibodies associated with headache with neurological deficits and cerebrospinal fluid lymphocytosis","volume":"9","author":"K\u00fcrt\u00fcnc\u00fc","year":"2008","journal-title":"J Headache Pain"},{"key":"R33-5-20211004","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/0333102412463494","article-title":"CACNA1H antibodies associated with headache with neurological deficits and cerebrospinal fluid lymphocytosis (HaNDL)","volume":"33","author":"K\u00fcrt\u00fcnc\u00fc","year":"2013","journal-title":"Cephalalgia"},{"key":"R34-5-20211004","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.celrep.2014.12.042","article-title":"The low-threshold calcium channel Cav3.2 determines low-threshold mechanoreceptor function","volume":"10","author":"Fran\u00e7ois","year":"2015","journal-title":"Cell Rep"},{"key":"R35-5-20211004","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s13760-014-0334-7","article-title":"Antibodies to DNA repair proteins in headache with neurological deficits and cerebrospinal fluid lymphocytosis (HaNDL) patients","volume":"115","author":"Erda\u011f","year":"2015","journal-title":"Acta Neurol Belg"},{"key":"R36-5-20211004","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med"},{"key":"R37-5-20211004","doi-asserted-by":"crossref","first-page":"e007766","DOI":"10.1136\/bmjopen-2015-007766","article-title":"Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis","volume":"5","author":"Nakajima","year":"2015","journal-title":"BMJ Open"},{"key":"R38-5-20211004","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrneurol.2014.129","article-title":"Pain in neuromyelitis optica: prevalence, pathogenesis and therapy","volume":"10","author":"Bradl","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"R39-5-20211004","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cca.2013.03.020","article-title":"Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks","volume":"421","author":"Uzawa","year":"2013","journal-title":"Clin Chim Acta"},{"key":"R40-5-20211004","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1073\/pnas.1017385108","article-title":"Interleukin 6 signaling promotes antiaquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica","volume":"108","author":"Chihara","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R41-5-20211004","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3109\/s10165-012-0715-9","article-title":"Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab","volume":"23","author":"Araki","year":"2013","journal-title":"Mod Rheumatol"},{"key":"R42-5-20211004","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/jamaneurol.2015.0533","article-title":"Long-term therapy with interleukin 6 receptor blockade in highly active neuromyelitis optica spectrum disorder","volume":"72","author":"Ringelstein","year":"2015","journal-title":"JAMA Neurol"},{"key":"R43-5-20211004","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.pain.2013.06.022","article-title":"Glia and pain: is chronic pain a gliopathy?","volume":"154","author":"Ji","year":"2013","journal-title":"Pain"},{"key":"R44-5-20211004","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.pain.2013.03.026","article-title":"Inhibition of IL-6 signaling: a novel therapeutic approach to treating spinal cord injury pain","volume":"154","author":"Guptarak","year":"2013","journal-title":"Pain"},{"key":"R45-5-20211004","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/rheumatology\/kem345","article-title":"A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg","volume":"47","author":"Caro","year":"2008","journal-title":"Rheumatology (Oxford"}],"container-title":["Current Opinion in Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01263393-201606000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T20:57:59Z","timestamp":1748897879000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01263393-201606000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0000000000000211","relation":{},"ISSN":["1751-4258"],"issn-type":[{"value":"1751-4258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}